0001567619-21-009211.txt : 20210506
0001567619-21-009211.hdr.sgml : 20210506
20210506163430
ACCESSION NUMBER: 0001567619-21-009211
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210505
FILED AS OF DATE: 20210506
DATE AS OF CHANGE: 20210506
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Peyer James
CENTRAL INDEX KEY: 0001843594
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39980
FILM NUMBER: 21898424
MAIL ADDRESS:
STREET 1: C/O SENSEI BIOTHERAPEUTICS, INC.
STREET 2: 1405 RESEARCH BLVD., STE. 125
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sensei Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001829802
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 620 PROFESSIONAL DRIVE
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: (240) 243-8000
MAIL ADDRESS:
STREET 1: 620 PROFESSIONAL DRIVE
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
doc1.xml
FORM 4
X0306
4
2021-05-05
0
0001829802
Sensei Biotherapeutics, Inc.
SNSE
0001843594
Peyer James
C/O SENSEI BIOTHERAPEUTICS, INC.
1405 RESEARCH BLVD. SUITE 125
ROCKVILLE
MD
20850
1
0
1
0
Common Stock
2021-05-05
4
P
0
350
12.00
A
4812244
I
See footnote
These shares are held by Cambrian Biopharma Inc, a Delaware corporation ("Cambrian"). The Reporting Person is the Chief Executive Officer of Cambrian and in such capacity may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.
/s/ Sarah Field, Attorney-in-Fact
2021-05-06